Skip to main content
Top
Published in: Critical Care 1/2015

Open Access 01-12-2015 | Research

Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental study

Authors: Cédric Dananché, Thomas Bénet, Bernard Allaouchiche, Romain Hernu, Laurent Argaud, Olivier Dauwalder, François Vandenesch, Philippe Vanhems

Published in: Critical Care | Issue 1/2015

Login to get access

Abstract

Introduction

Identification of third-generation, cephalosporin-resistant Enterobacteriaceae (3GC-RE) carriers by rectal screening at admission seems to be an important step in the prevention of transmission and outbreaks; however, little is known about its effectiveness. The aim of this study was to evaluate the impact of ‘targeted screening’ at patient admission to intensive care units (ICUs) on the incidence of 3GC-RE hospital-acquired infections (HAIs) and compare it to ‘universal screening’.

Methods

We undertook a quasi-experimental study of two ICUs (unit A: intervention group; unit B: control group) at a university-affiliated hospital between 1 January 2008 and 31 December 2011. In unit A, patients were screened universally for 3GC-RE at admission during period 1 (1 January 2008 through 30 September 2010). During period 2 (2011 calendar year), the intervention was implemented in unit A; patients transferred from another unit or hospital were screened selectively. In unit B, all patients were screened throughout periods 1 and 2. 3GC-RE-related HAI incidence rates were expressed per 1,000 patient-days. Incidence rate ratios (IRRs) were examined by multivariate Poisson regression modelling.

Results

In unit A, 3GC-RE-related HAI incidence rates decreased from 5.4 (95% confidence interval (CI), 4.1 to 7.0) during period 1 to 1.3 (95% CI, 0.5 to 2.9) during period 2 (P < 0.001). No changes were observed in unit B between periods 1 and 2 (P = 0.5). In unit A, the adjusted incidence of 3GC-RE-related HAIs decreased in period 2 compared with period 1 (adjusted IRR, 0.3; 95% CI, 0.1 to 0.9; P = 0.03) independently of temporal trend, trauma and age. No changes were seen in unit B (P = 0.4). The total number of rectal swabs taken showed an 85% decrease in unit A between period 1 and 2 (P < 0.001).

Conclusions

Targeted screening of 3GC-RE carriers at ICU admission was not associated with an increase in 3GC-RE-related HAI incidence compared with universal screening. Total number of rectal swabs decreased significantly. These findings suggest that targeted screening may be worth assessing as an alternative to universal screening.
Literature
1.
go back to reference Paterson DL. Resistance in Gram-negative bacteria: Enterobacteriaceae. Am J Infect Control. 2006;34:S20–8. discussion S64–S73.CrossRef Paterson DL. Resistance in Gram-negative bacteria: Enterobacteriaceae. Am J Infect Control. 2006;34:S20–8. discussion S64–S73.CrossRef
2.
go back to reference Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol. 2004;42:4769–75.CrossRef Valverde A, Coque TM, Sánchez-Moreno MP, Rollán A, Baquero F, Cantón R. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol. 2004;42:4769–75.CrossRef
5.
go back to reference Lucet JC. Birgand G [Multiply resistant Gram-negative bacteria: where do we go from here?]. J Antiinfect. 2011;13:122–32. doi:10.1016/j.antinf.2011.03.006. French. Lucet JC. Birgand G [Multiply resistant Gram-negative bacteria: where do we go from here?]. J Antiinfect. 2011;13:122–32. doi:10.1016/j.antinf.2011.03.006. French.
6.
go back to reference Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159–66.CrossRef Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159–66.CrossRef
7.
go back to reference Khan AS, Dancer SJ, Humphreys H. Priorities in the prevention and control of multidrug-resistant Enterobacteriaceae in hospitals. J Hosp Infect. 2012;82:85–93.CrossRef Khan AS, Dancer SJ, Humphreys H. Priorities in the prevention and control of multidrug-resistant Enterobacteriaceae in hospitals. J Hosp Infect. 2012;82:85–93.CrossRef
8.
go back to reference Lucet JC, Decré D, Fichelle A, Joly-Guillou ML, Pernet M, Deblangy C, et al. Control of a prolonged outbreak of extended-spectrum β-lactamase-producing Enterobacteriaceae in a university hospital. Clin Infect Dis. 1999;29:1411–8.CrossRef Lucet JC, Decré D, Fichelle A, Joly-Guillou ML, Pernet M, Deblangy C, et al. Control of a prolonged outbreak of extended-spectrum β-lactamase-producing Enterobacteriaceae in a university hospital. Clin Infect Dis. 1999;29:1411–8.CrossRef
9.
go back to reference Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657–86.CrossRef Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev. 2005;18:657–86.CrossRef
10.
go back to reference Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35:S165–93.CrossRef Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35:S165–93.CrossRef
11.
go back to reference Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control. 2007;35:S65–164.CrossRef Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control. 2007;35:S65–164.CrossRef
12.
go back to reference Goddard S, Muller MP. The efficacy of infection control interventions in reducing the incidence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the nonoutbreak setting: a systematic review. Am J Infect Control. 2011;39:599–601.CrossRef Goddard S, Muller MP. The efficacy of infection control interventions in reducing the incidence of extended-spectrum β-lactamase-producing Enterobacteriaceae in the nonoutbreak setting: a systematic review. Am J Infect Control. 2011;39:599–601.CrossRef
13.
go back to reference Lowe C, Katz K, McGeer A, Muller MP. Disparity in infection control practices for multidrug-resistant Enterobacteriaceae. Am J Infect Control. 2012;40:836–9.CrossRef Lowe C, Katz K, McGeer A, Muller MP. Disparity in infection control practices for multidrug-resistant Enterobacteriaceae. Am J Infect Control. 2012;40:836–9.CrossRef
14.
go back to reference Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20:1–55.CrossRef Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20:1–55.CrossRef
15.
go back to reference Gardam MA, Burrows LL, Kus JV, Brunton J, Low DE, Conly JM, et al. Is surveillance for multidrug-resistant Enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis. 2002;186:1754–60.CrossRef Gardam MA, Burrows LL, Kus JV, Brunton J, Low DE, Conly JM, et al. Is surveillance for multidrug-resistant Enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis. 2002;186:1754–60.CrossRef
16.
go back to reference Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum β-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol. 2004;25:838–41.CrossRef Thouverez M, Talon D, Bertrand X. Control of Enterobacteriaceae producing extended-spectrum β-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations. Infect Control Hosp Epidemiol. 2004;25:838–41.CrossRef
17.
go back to reference Schnell D, Kouatchet AT, Lécuyer H, Talbi A, Descamps P, Nassif X, et al. Is extended-spectrum β-lactamase-producing Escherichia coli rectal carriage at hospital admission predictable? Risk factors at hospital admission. J Hosp Infect. 2010;76:178–80.CrossRef Schnell D, Kouatchet AT, Lécuyer H, Talbi A, Descamps P, Nassif X, et al. Is extended-spectrum β-lactamase-producing Escherichia coli rectal carriage at hospital admission predictable? Risk factors at hospital admission. J Hosp Infect. 2010;76:178–80.CrossRef
18.
go back to reference Meyer E, Serr A, Schneider C, Utzolino S, Kern WV, Scholz R, et al. Should we screen patients for extended‐spectrum β‐lactamase–producing Enterobacteriaceae in intensive care units? Infect Control Hosp Epidemiol. 2009;30:103–5.CrossRef Meyer E, Serr A, Schneider C, Utzolino S, Kern WV, Scholz R, et al. Should we screen patients for extended‐spectrum β‐lactamase–producing Enterobacteriaceae in intensive care units? Infect Control Hosp Epidemiol. 2009;30:103–5.CrossRef
19.
go back to reference Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, et al. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis. 2006;42:925–34.CrossRef Ben-Ami R, Schwaber MJ, Navon-Venezia S, Schwartz D, Giladi M, Chmelnitsky I, et al. Influx of extended-spectrum β-lactamase-producing Enterobacteriaceae into the hospital. Clin Infect Dis. 2006;42:925–34.CrossRef
20.
go back to reference Friedmann R, Raveh D, Zartzer E, Rudensky B, Broide E, Attias D, et al. Prospective evaluation of colonization with extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol. 2009;30:534–42.CrossRef Friedmann R, Raveh D, Zartzer E, Rudensky B, Broide E, Attias D, et al. Prospective evaluation of colonization with extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing Enterobacteriaceae among patients during hospitalization. Infect Control Hosp Epidemiol. 2009;30:534–42.CrossRef
21.
go back to reference Azim A, Dwivedi M, Rao PB, Baronia AK, Singh RK, Prasad KN, et al. Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum β-lactamase- and metallo-β-lactamase-producing Gram-negative bacteria – an Indian experience. J Med Microbiol. 2010;59:955–60.CrossRef Azim A, Dwivedi M, Rao PB, Baronia AK, Singh RK, Prasad KN, et al. Epidemiology of bacterial colonization at intensive care unit admission with emphasis on extended-spectrum β-lactamase- and metallo-β-lactamase-producing Gram-negative bacteria – an Indian experience. J Med Microbiol. 2010;59:955–60.CrossRef
22.
go back to reference Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, et al. Risk factors for colonization with extended-spectrum β-lactamase–producing bacteria and intensive care unit admission. Emerg Infect Dis. 2007;13:1144–9.CrossRef Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, et al. Risk factors for colonization with extended-spectrum β-lactamase–producing bacteria and intensive care unit admission. Emerg Infect Dis. 2007;13:1144–9.CrossRef
23.
go back to reference Razazi K, Derde LPG, Verachten M, Legrand P, Lesprit P, Brun-Buisson C. Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit. Intensive Care Med. 2012;38:1769–78.CrossRef Razazi K, Derde LPG, Verachten M, Legrand P, Lesprit P, Brun-Buisson C. Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit. Intensive Care Med. 2012;38:1769–78.CrossRef
25.
go back to reference Januel JM, Harbarth S, Allard R, Voirin N, Lepape A, Allaouchiche B, et al. Estimating attributable mortality due to nosocomial infections acquired in intensive care units. Infect Control Hosp Epidemiol. 2010;31:388–94.CrossRef Januel JM, Harbarth S, Allard R, Voirin N, Lepape A, Allaouchiche B, et al. Estimating attributable mortality due to nosocomial infections acquired in intensive care units. Infect Control Hosp Epidemiol. 2010;31:388–94.CrossRef
26.
go back to reference Bénet T, Allaouchiche B, Argaud L, Vanhems P. Impact of surveillance of hospital-acquired infections on the incidence of ventilator-associated pneumonia in intensive care units: a quasi-experimental study. Crit Care. 2012;16:R161.CrossRef Bénet T, Allaouchiche B, Argaud L, Vanhems P. Impact of surveillance of hospital-acquired infections on the incidence of ventilator-associated pneumonia in intensive care units: a quasi-experimental study. Crit Care. 2012;16:R161.CrossRef
27.
go back to reference Centers for Disease Control and Prevention, Healthcare Infection Control Practices Advisory Committee (HIPAC). 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Part III: precautions to prevent transmission of infectious agents. http://www.cdc.gov/hicpac/2007IP/2007ip_part3.html. Accessed 6 Feb 2015. Centers for Disease Control and Prevention, Healthcare Infection Control Practices Advisory Committee (HIPAC). 2007 Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Part III: precautions to prevent transmission of infectious agents. http://​www.​cdc.​gov/​hicpac/​2007IP/​2007ip_​part3.​html. Accessed 6 Feb 2015.
30.
go back to reference Leonhardt KK, Yakusheva O, Phelan D, Reeths A, Hosterman T, Bonin D, et al. Clinical effectiveness and cost benefit of universal versus targeted methicillin-resistant Staphylococcus aureus screening upon admission in hospitals. Infect Control Hosp Epidemiol. 2011;32:797–803.CrossRef Leonhardt KK, Yakusheva O, Phelan D, Reeths A, Hosterman T, Bonin D, et al. Clinical effectiveness and cost benefit of universal versus targeted methicillin-resistant Staphylococcus aureus screening upon admission in hospitals. Infect Control Hosp Epidemiol. 2011;32:797–803.CrossRef
31.
go back to reference Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin‐resistant Staphylococcus aureus and vancomycin‐resistant Enterococci: position statement from the joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol. 2007;28:249–60.CrossRef Weber SG, Huang SS, Oriola S, Huskins WC, Noskin GA, Harriman K, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin‐resistant Staphylococcus aureus and vancomycin‐resistant Enterococci: position statement from the joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol. 2007;28:249–60.CrossRef
32.
go back to reference Harris AD, Kotetishvili M, Shurland S, Johnson JA, Morris JG, Nemoy LL, et al. How important is patient-to-patient transmission in extended-spectrum β-lactamase Escherichia coli acquisition. Am J Infect Control. 2007;35:97–101.CrossRef Harris AD, Kotetishvili M, Shurland S, Johnson JA, Morris JG, Nemoy LL, et al. How important is patient-to-patient transmission in extended-spectrum β-lactamase Escherichia coli acquisition. Am J Infect Control. 2007;35:97–101.CrossRef
33.
go back to reference Harris AD, Perencevich EN, Johnson JK, Paterson DL, Morris JG, Strauss SM, et al. Patient-to-patient transmission is important in extended-spectrum β-lactamase–producing Klebsiella pneumoniae acquisition. Clin Infect Dis. 2007;45:1347–50.CrossRef Harris AD, Perencevich EN, Johnson JK, Paterson DL, Morris JG, Strauss SM, et al. Patient-to-patient transmission is important in extended-spectrum β-lactamase–producing Klebsiella pneumoniae acquisition. Clin Infect Dis. 2007;45:1347–50.CrossRef
34.
go back to reference Harris AD, McGregor JC, Furuno JP. What infection control interventions should be undertaken to control multidrug-resistant Gram-negative bacteria? Clin Infect Dis. 2006;43:S57–61.CrossRef Harris AD, McGregor JC, Furuno JP. What infection control interventions should be undertaken to control multidrug-resistant Gram-negative bacteria? Clin Infect Dis. 2006;43:S57–61.CrossRef
35.
go back to reference Vodovar D, Marcadé G, Raskine L, Malissin I, Mégarbane B. Enterobacteriaceae producing extended spectrum β-lactamase: epidemiology, risk factors, and prevention. Rev Med Interne. 2013;34:687–93. French.CrossRef Vodovar D, Marcadé G, Raskine L, Malissin I, Mégarbane B. Enterobacteriaceae producing extended spectrum β-lactamase: epidemiology, risk factors, and prevention. Rev Med Interne. 2013;34:687–93. French.CrossRef
36.
go back to reference Conterno LO, Shymanski J, Ramotar K, Toye B, Zvonar R, Roth V. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum β-lactamase-producing organisms in a non-outbreak setting. J Hosp Infect. 2007;65:354–60.CrossRef Conterno LO, Shymanski J, Ramotar K, Toye B, Zvonar R, Roth V. Impact and cost of infection control measures to reduce nosocomial transmission of extended-spectrum β-lactamase-producing organisms in a non-outbreak setting. J Hosp Infect. 2007;65:354–60.CrossRef
37.
go back to reference Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013;368:2255–65.CrossRef Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med. 2013;368:2255–65.CrossRef
38.
go back to reference Troché G, Joly L, Guibert M, Zazzo J. Detection and treatment of antibiotic‐resistant bacterial carriage in a surgical intensive care unit: a 6‐year prospective survey. Infect Control Hosp Epidemiol. 2005;26:161–5.CrossRef Troché G, Joly L, Guibert M, Zazzo J. Detection and treatment of antibiotic‐resistant bacterial carriage in a surgical intensive care unit: a 6‐year prospective survey. Infect Control Hosp Epidemiol. 2005;26:161–5.CrossRef
39.
go back to reference Biehl LM, Schmidt-Hieber M, Liss B, Cornely OA, Vehreschild MJGT. Colonization and infection with extended spectrum β-lactamase producing Enterobacteriaceae in high-risk patients: review of the literature from a clinical perspective. Crit Rev Microbiol. In press. doi:10.3109/1040841X.2013.875515. Biehl LM, Schmidt-Hieber M, Liss B, Cornely OA, Vehreschild MJGT. Colonization and infection with extended spectrum β-lactamase producing Enterobacteriaceae in high-risk patients: review of the literature from a clinical perspective. Crit Rev Microbiol. In press. doi:10.3109/1040841X.2013.875515.
40.
go back to reference Lowe CF, Katz K, McGeer AJ, Muller MP, for the Toronto ESBL Working Group. Efficacy of admission screening for extended-spectrum β-lactamase producing Enterobacteriaceae. PLoS One. 2013;8:e62678.CrossRef Lowe CF, Katz K, McGeer AJ, Muller MP, for the Toronto ESBL Working Group. Efficacy of admission screening for extended-spectrum β-lactamase producing Enterobacteriaceae. PLoS One. 2013;8:e62678.CrossRef
41.
go back to reference Harris AD, Bradham DD, Baumgarten M, Zuckerman IH, Fink JC, Perencevich EN. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis. 2004;38:1586–91.CrossRef Harris AD, Bradham DD, Baumgarten M, Zuckerman IH, Fink JC, Perencevich EN. The use and interpretation of quasi-experimental studies in infectious diseases. Clin Infect Dis. 2004;38:1586–91.CrossRef
42.
go back to reference Harris AD, Lautenbach E, Perencevich E. A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clin Infect Dis. 2005;41:77–82.CrossRef Harris AD, Lautenbach E, Perencevich E. A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clin Infect Dis. 2005;41:77–82.CrossRef
43.
go back to reference Shardell M, Harris AD, El-Kamary SS, Furuno JP, Miller RR, Perencevich EN. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis. 2007;45:901–7.CrossRef Shardell M, Harris AD, El-Kamary SS, Furuno JP, Miller RR, Perencevich EN. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis. 2007;45:901–7.CrossRef
44.
go back to reference Courpon-Claudinon A, Lefort A, Panhard X, Clermont O, Dornic Q, Fantin B, et al. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect. 2011;17:557–65.CrossRef Courpon-Claudinon A, Lefort A, Panhard X, Clermont O, Dornic Q, Fantin B, et al. Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features. Clin Microbiol Infect. 2011;17:557–65.CrossRef
Metadata
Title
Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental study
Authors
Cédric Dananché
Thomas Bénet
Bernard Allaouchiche
Romain Hernu
Laurent Argaud
Olivier Dauwalder
François Vandenesch
Philippe Vanhems
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2015
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-015-0754-7

Other articles of this Issue 1/2015

Critical Care 1/2015 Go to the issue